Oligoadenylatsynthetase 1 (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Oligoadenylatsynthetase 1" in German language version.

refsWebsite
Global rank German rank
2nd place
3rd place
4th place
7th place

doi.org

  • V. K. Vachon, B. M. Calderon, G. L. Conn: A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1. In: Nucleic acids research. Band 43, Nummer 1, Januar 2015, S. 544–552, doi:10.1093/nar/gku1289, PMID 25477390, PMC 4288181 (freier Volltext).
  • A. Mozzi, C. Pontremoli, D. Forni, M. Clerici, U. Pozzoli, N. Bresolin, R. Cagliani, M. Sironi: OASes and STING: adaptive evolution in concert. In: Genome biology and evolution. [elektronische Veröffentlichung vor dem Druck] März 2015, doi:10.1093/gbe/evv046, PMID 25752600.
  • S. Deo, T. R. Patel, E. Dzananovic, E. P. Booy, K. Zeid, K. McEleney, S. E. Harding, S. A. McKenna: Activation of 2' 5'-oligoadenylate synthetase by stem loops at the 5'-end of the West Nile virus genome. In: PloS one. Band 9, Nummer 3, 2014, S. e92545, doi:10.1371/journal.pone.0092545, PMID 24651762, PMC 3961380 (freier Volltext).
  • J. K. Lim, A. Lisco, D. H. McDermott, L. Huynh, J. M. Ward, B. Johnson, H. Johnson, J. Pape, G. A. Foster, D. Krysztof, D. Follmann, S. L. Stramer, L. B. Margolis, P. M. Murphy: Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. In: PLoS pathogens. Band 5, Nummer 2, Februar 2009, S. e1000321, doi:10.1371/journal.ppat.1000321, PMID 19247438, PMC 2642680 (freier Volltext).
  • M. O’Brien, R. Lonergan, L. Costelloe, K. O’Rourke, J. M. Fletcher, K. Kinsella, C. Sweeney, G. Antonelli, K. H. Mills, C. O’Farrelly, M. Hutchinson, N. Tubridy: OAS1: a multiple sclerosis susceptibility gene that influences disease severity. In: Neurology. Band 75, Nummer 5, August 2010, S. 411–418, doi:10.1212/WNL.0b013e3181ebdd2b, PMID 20679634.

nih.gov

ncbi.nlm.nih.gov

  • V. K. Vachon, B. M. Calderon, G. L. Conn: A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1. In: Nucleic acids research. Band 43, Nummer 1, Januar 2015, S. 544–552, doi:10.1093/nar/gku1289, PMID 25477390, PMC 4288181 (freier Volltext).
  • A. Mozzi, C. Pontremoli, D. Forni, M. Clerici, U. Pozzoli, N. Bresolin, R. Cagliani, M. Sironi: OASes and STING: adaptive evolution in concert. In: Genome biology and evolution. [elektronische Veröffentlichung vor dem Druck] März 2015, doi:10.1093/gbe/evv046, PMID 25752600.
  • S. Deo, T. R. Patel, E. Dzananovic, E. P. Booy, K. Zeid, K. McEleney, S. E. Harding, S. A. McKenna: Activation of 2' 5'-oligoadenylate synthetase by stem loops at the 5'-end of the West Nile virus genome. In: PloS one. Band 9, Nummer 3, 2014, S. e92545, doi:10.1371/journal.pone.0092545, PMID 24651762, PMC 3961380 (freier Volltext).
  • J. K. Lim, A. Lisco, D. H. McDermott, L. Huynh, J. M. Ward, B. Johnson, H. Johnson, J. Pape, G. A. Foster, D. Krysztof, D. Follmann, S. L. Stramer, L. B. Margolis, P. M. Murphy: Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. In: PLoS pathogens. Band 5, Nummer 2, Februar 2009, S. e1000321, doi:10.1371/journal.ppat.1000321, PMID 19247438, PMC 2642680 (freier Volltext).
  • M. O’Brien, R. Lonergan, L. Costelloe, K. O’Rourke, J. M. Fletcher, K. Kinsella, C. Sweeney, G. Antonelli, K. H. Mills, C. O’Farrelly, M. Hutchinson, N. Tubridy: OAS1: a multiple sclerosis susceptibility gene that influences disease severity. In: Neurology. Band 75, Nummer 5, August 2010, S. 411–418, doi:10.1212/WNL.0b013e3181ebdd2b, PMID 20679634.